MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Demchyshyn, L. L.
Right arrow Articles by Niznik, H. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Demchyshyn, L. L.
Right arrow Articles by Niznik, H. B.

Cloning and expression of a human somatostatin-14-selective receptor variant (somatostatin receptor 4) located on chromosome 20

LL Demchyshyn, CB Srikant, RK Sunahara, G Kent, P Seeman, HH Van Tol, R Panetta, YC Patel and HB Niznik

Department of Psychiatry, University of Toronto, Canada.

Based on pharmacological, biochemical, and molecular criteria, multiple somatostatin receptor (SSTR) subtypes selective for somatostatin (SST)- 14 and -28 have been postulated to exist in both the brain and periphery. We report here on the cloning and characterization of a human gene encoding a new member of the guanine nucleotide-binding protein-linked SSTR family, termed human (h)SSTR4. The 388-amino acid protein, with a predicted molecular mass of approximately 42 kDa, displays sequence similarity, particularly within putative transmembrane domains, with the recently cloned hSSTR1 (69%), hSSTR2 (56%), and hSSTR3 (58%). Membranes prepared from COS-7 cells transiently expressing the hSSTR4 gene bound 125I-[Leu8,D- Trp22,Tyr25]SST-28 in a saturable manner with high affinity (approximately 60 pM) and with a pharmacological profile and rank order of potency ([D-Trp8]SST-14 > SST-14 > SMS 201-995 > SST-28 > MK-678) indicative of a SST-14-selective receptor. Ki values for the inhibition of 125I-[Leu8,D-Trp22,Tyr25]SST-28 binding to the expressed receptor by these somatostatinergic peptides were 0.3, 1.1, 1.4, 2.2, and 6.5 nM, respectively. High affinity agonist binding to hSSTR4 was significantly reduced by GTP and pertussis toxin, indicating association of the expressed receptor with pertussis toxin-sensitive guanine nucleotide- binding proteins. Northern blot analysis revealed the presence of an SSTR4 mRNA species of approximately 4 kilobases in select regions of the monkey brain, including the hippocampus, hypothalamus, cortex, and striatum, with little or no receptor mRNA detected in either the olfactory tubercle, medulla, cerebellum, or amygdala. The SSTR4 gene maps to human chromosome 20. These findings document the existence of a novel human SSTR gene. Although the hSSTR4 displays an overall deduced amino acid homology of 86% with the recently reported rat homolog [Proc. Natl. Acad. Sci. USA 89:11151-11155 (1992)], the two gene products possess distinctive pharmacological profiles and affinities for the SST agonists SMS 201-995 and MK-678.

Volume 43, Issue 6, pp. 894-901, 06/01/1993
Copyright © 1993 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
JNMHome page
G. Burggasser, I. Hurtl, W. Hauff, J. Lukas, M. Greifeneder, B. Heydari, A. Thaler, A. Wedrich, and I. Virgolini
Orbital Scintigraphy with the Somatostatin Receptor Tracer 99mTc-P829 in Patients with Graves' Disease
J. Nucl. Med., October 1, 2003; 44(10): 1547 - 1555.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
T. Traub, V. Petkov, S. Ofluoglu, T. Pangerl, M. Raderer, B. J. Fueger, W. Schima, A. Kurtaran, R. Dudczak, and I. Virgolini
111In-DOTA-Lanreotide Scintigraphy in Patients with Tumors of the Lung
J. Nucl. Med., September 1, 2001; 42(9): 1309 - 1315.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. M. Smith-Jones, C. Bischof, M. Leimer, D. Gludovacz, P. Angelberger, T. Pangerl, M. Peck-Radosavljevic, G. Hamilton, K. Kaserer, A. Kofler, et al.
DOTA-Lanreotide: A Novel Somatostatin Analog for Tumor Diagnosis and Therapy
Endocrinology, November 1, 1999; 140(11): 5136 - 5148.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Jaquet, L. Ouafik, A. Saveanu, G. Gunz, F. Fina, H. Dufour, M. D. Culler, J. P. Moreau, and A. Enjalbert
Quantitative and Functional Expression of Somatostatin Receptor Subtypes in Human Prolactinomas
J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3268 - 3276.
[Abstract] [Full Text]


Home page
IOVSHome page
L. Helboe and M. Moller
Immunohistochemical Localization of Somatostatin Receptor Subtypes sst1 and sst2 in the Rat Retina
Invest. Ophthalmol. Vis. Sci., September 1, 1999; 40(10): 2376 - 2382.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. Helboe, C. E. Stidsen, and M. Moller
Immunohistochemical and Cytochemical Localization of the Somatostatin Receptor Subtype sst1 in the Somatostatinergic Parvocellular Neuronal System of the Rat Hypothalamus
J. Neurosci., July 1, 1998; 18(13): 4938 - 4945.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1993 by the American Society for Pharmacology and Experimental Therapeutics